Glioma CSCs isolated from human glioma xenografts and primary glioblastoma produce radio-resistance by preferential activation of the DNA damage response, and the radio-resistance of CSCs could be reversed by specific inhibition of Chk1 and Chk2 checkpoint kinases, upstream activators of p53 [61]. This evidence concerns the gene CHEK2 and central nervous system cancer.